UK Regulator Blocks Wockhardt European Drug Sales

Law360, New York (July 10, 2013, 2:31 PM EDT) -- The recent troubles for Indian drug manufacturer Wockhardt Ltd. continued Wednesday as a British regulator announced it was banning the company’s drugs in Europe due to manufacturing violations, a move that comes weeks after the U.S. issued its own import restrictions.

The U.K.’s Medicines and Healthcare Products Regulatory Agency says that Wockhardt will be banned from making medicine for Europe following the agency’s determination that an Indian manufacturing facility was in violation of good manufacturing practices. The agency said a routine March inspection uncovered a risk...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.